Further, these data support that obesity-induced inflammation is governed by the sEV/ATM axis, which not only provides mechanistic details of AT inflammation in metabolic disease, but also opens for a new approach to treating such diseases. This evidence concerns the gene ATM and obesity due to melanocortin 4 receptor deficiency.